Bowhead Specialty (NYSE:BOW) Price Target Raised to $44.00

Bowhead Specialty (NYSE:BOW) had its target price raised by Keefe, Bruyette & Woods from $36.00 to $44.00 in a report published on Friday morning,Benzinga reports. Keefe, Bruyette & Woods currently has a market perform rating on the stock.

Other equities analysts have also issued research reports about the stock. JPMorgan Chase & Co. upped their price objective on shares of Bowhead Specialty from $26.00 to $30.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Royal Bank of Canada increased their price target on Bowhead Specialty from $32.00 to $35.00 and gave the stock an “outperform” rating in a report on Wednesday, November 6th. Finally, JMP Securities boosted their price objective on Bowhead Specialty from $32.00 to $33.00 and gave the company a “market outperform” rating in a report on Wednesday, November 6th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, Bowhead Specialty presently has a consensus rating of “Hold” and a consensus price target of $33.60.

Bowhead Specialty Price Performance

Shares of NYSE:BOW opened at $31.84 on Friday. The business’s 50-day moving average is $34.52 and its 200-day moving average is $30.48. Bowhead Specialty has a 1 year low of $22.14 and a 1 year high of $37.81.

Bowhead Specialty (NYSE:BOW) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.38 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.38. The business had revenue of $116.76 million for the quarter, compared to the consensus estimate of $113.00 million. Equities analysts anticipate that Bowhead Specialty will post 1.38 EPS for the current fiscal year.

Insider Transactions at Bowhead Specialty

In other news, Director Family Mutual Insuran American sold 1,362,285 shares of the stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $27.70, for a total value of $37,735,294.50. Following the completion of the sale, the director now owns 4,700,761 shares in the company, valued at $130,211,079.70. This represents a 22.47 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Institutional Investors Weigh In On Bowhead Specialty

A number of institutional investors have recently added to or reduced their stakes in BOW. JPMorgan Chase & Co. bought a new position in shares of Bowhead Specialty during the 3rd quarter worth approximately $1,382,000. Lord Abbett & CO. LLC lifted its holdings in Bowhead Specialty by 10.9% during the third quarter. Lord Abbett & CO. LLC now owns 257,870 shares of the company’s stock worth $7,223,000 after acquiring an additional 25,304 shares during the period. Barclays PLC bought a new stake in Bowhead Specialty during the third quarter worth $479,000. Geode Capital Management LLC purchased a new position in Bowhead Specialty in the third quarter worth $4,691,000. Finally, American Family Investments Inc. bought a new position in Bowhead Specialty in the 3rd quarter valued at $169,826,000.

About Bowhead Specialty

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.